Literature DB >> 6440174

Chronic and acute administration of typical and atypical antidepressants on activity of brain noradrenaline systems in the rat thiopentone anaesthesia model.

S T Mason, A Angel.   

Abstract

A behavioural model sensitive to manipulation of brain noradrenaline systems and with characteristics of beta-receptor mediation has been developed using the duration of thiopentone anaesthesia in the rat. Acute and chronic administration of various antidepressant agents was examined. In the acute phase, (30 min prior to thiopentone) the noradrenaline uptake-inhibiting tricyclic drugs and viloxazine increased anaesthesia duration in a dose-dependent fashion. The atypical antidepressants trazodone, iprindole, and mianserin did this only weakly, while the dopaminergic and serotonergic uptake-inhibiting antidepressants (respectively bupropion, nomifensine, and zimelidine, fluoxetine) markedly shortened anaesthesia duration. Chronic administration (for 15 days) prolonged anaesthesia duration measured 2 or 5 days after the last drug injection for all tricyclic agents, for the atypical antidepressants mianserin, iprindole, fluoxetine, and zimelidine, and for viloxazine.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6440174     DOI: 10.1007/bf00555203

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  25 in total

1.  Tricyclic antidepressants: effects on the firing rate of brain noradrenergic neurons.

Authors:  H V Nybäck; J R Walters; G K Aghajanian; R H Roth
Journal:  Eur J Pharmacol       Date:  1975 Jun-Jul       Impact factor: 4.432

2.  Intact presynaptic terminals required for beta-adrenergic receptor regulation by desipramine.

Authors:  J W Schweitzer; R Schwartz; A J Friedhoff
Journal:  J Neurochem       Date:  1979-07       Impact factor: 5.372

3.  A comparison of the inhibitory activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slices.

Authors:  S B Ross; A L Renyi; S O Ogren
Journal:  Life Sci I       Date:  1971-11-15

4.  Role of neuronal signal input in the down-regulation of central noradrenergic receptor function by antidepressant drugs.

Authors:  A Janowsky; L R Steranka; D D Gillespie; F Sulser
Journal:  J Neurochem       Date:  1982-07       Impact factor: 5.372

5.  The effects of amitriptyline, mianserin, phenoxybenzamine and propranolol on the release of noradrealine in the rat brain in vivo.

Authors:  J M Fludder; B E Leonard
Journal:  Biochem Pharmacol       Date:  1979-08-01       Impact factor: 5.858

6.  Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycol-sulphate and total 3-methoxy-4-hydroxyphenylglycol in the rat brain.

Authors:  M Nielsen; C Braestrup
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

7.  Inhibition of the neuronal uptake of 5-hydroxytryptamine and noradrenaline in rat brain by (Z)- and (E)-3-(4-bromophenyl)-N,N-dimethyl-3-(3-pyridyl) allylamines and their secondary analogues.

Authors:  S B Ross; A L Renyi
Journal:  Neuropharmacology       Date:  1977-01       Impact factor: 5.250

8.  Behavioural evidence that chronic treatment with the antidepressant desipramine causes reduced functioning of brain noradrenaline systems.

Authors:  S T Mason; A Angel
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain.

Authors:  B K Koe
Journal:  J Pharmacol Exp Ther       Date:  1976-12       Impact factor: 4.030

10.  Daily bupropion injections for 3 weeks attenuate the NE stimulation of adenylate cyclase and the number of beta-adrenergic recognition sites in rat frontal cortex.

Authors:  O Gandolfi; M L Barbaccia; D M Chuang; E Costa
Journal:  Neuropharmacology       Date:  1983-07       Impact factor: 5.250

View more
  3 in total

Review 1.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

Review 2.  Fluoxetine: a review of receptor and functional effects and their clinical implications.

Authors:  C M Beasley; D N Masica; J H Potvin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Crucial role of zebrafish prox1 in hypothalamic catecholaminergic neurons development.

Authors:  Anna Pistocchi; Germano Gaudenzi; Silvia Carra; Erica Bresciani; Luca Del Giacco; Franco Cotelli
Journal:  BMC Dev Biol       Date:  2008-03-10       Impact factor: 1.978

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.